LEADER 02431oas  2201021 a 450 
001 9910154513903321
005 20251105213014.0
011   $a1029-2403
035   $a(DE-599)ZDB2030637-4
035   $a(OCoLC)50166437
035   $a(CONSER)  2007233250
035   $a(CKB)954925589387
035   $a(EXLCZ)99954925589387
100   $a20020713a19899999  sy 
101 0 $aeng
135   $aurmnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aLeukemia & lymphoma
210   $aChur ;$aNew York $cHarwood Academic Publishers ;$aLondon, UK $cDistributed by STBS$d1989-
210 2 $aLondon $cInforma Healthcare
210 31$a[Philadelphia, PA] :$cTaylor & Francis
300   $aRefereed/Peer-reviewed
300   $aPublished: Taylor & Francis, <2002->
311 08$a1042-8194 
517 3 $aLeukemia and lymphoma
606   $aLeukemia$vPeriodicals
606   $aLymphomas$vPeriodicals
606   $aLeukemia
606   $aLymphoma
606   $aLeuce?mie$vPe?riodiques
606   $aLymphome$vPe?riodiques
606   $aOncology$2ebps
606   $aLeukemia$2fast$3(OCoLC)fst00996894
606   $aLymphomas$2fast$3(OCoLC)fst01004321
608   $aPeriodical.
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
615  0$aLeukemia
615  0$aLymphomas
615  2$aLeukemia.
615  2$aLymphoma.
615  6$aLeuce?mie
615  6$aLymphome
615  7$aOncology.
615  7$aLeukemia.
615  7$aLymphomas.
676   $a616.99419
801  0$bF#A
801  1$bF#A
801  2$bOCLCQ
801  2$bHUA
801  2$bOCLCS
801  2$bGUA
801  2$bOCLCQ
801  2$bUKMGB
801  2$bOCLCQ
801  2$bOCLCF
801  2$bOCLCQ
801  2$bWT2
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCA
801  2$bOCLCQ
801  2$bNLE
801  2$bAU@
801  2$bOCLCO
801  2$bWYU
801  2$bOCLCO
801  2$bOCLCA
801  2$bVT2
801  2$bNLM
801  2$bAUD
801  2$bOCLCQ
801  2$bSXB
801  2$bUBY
801  2$bOCLCO
801  2$bIBD
801  2$bCNMTR
801  2$bOCLCQ
801  2$bOCLCL
801  2$bUEJ
801  2$bOCLCQ
906   $aJOURNAL
912   $a9910154513903321
996   $aLeukemia & lymphoma$9791141
997   $aUNINA